Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MRT 67307 dihydrochloride 是 IKKε 和 TBK-1 的双抑制剂,IC50 分别为 160 和 19 nM。MRT 67307 dihydrochloride 也可抑制 ULK1 和 ULK2,IC50 分别为 45 和 38 nM。MRT 67307 dihydrochloride 还抑制细胞自噬 (autophagy)。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 262 | 现货 | ||
5 mg | ¥ 597 | 现货 | ||
10 mg | 特惠询价 | 现货 | ||
50 mg | 特惠询价 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 795 | 现货 |
产品描述 | MRT 67307 dihydrochloride is a dual inhibitor of the IKKε and TBK-1 with IC50s of 160 and 19 nM, respectively. MRT67307 dihydrochloride also inhibits ULK1 and ULK2 with IC50s of 45 and 38 nM, respectively. MRT67307 dihydrochloride also blocks autophagy in cells. |
体外活性 | MRT 67307 dihydrochloride inhibits IKKϵ and TBK1 with IC50 of 160 and 19 nM when assayed at 0.1 mM ATP in vitro, but did not inhibit IKKα or IKKβ even at 10 μM[1]. MRT 67307 dihydrochloride (2 μM) prevents the phosphorylation of IRF3 in bone-marrow-derived macrophages (BMDMs). MRT 67307 dihydrochloride (2 μM) dose not suppresse the activation of JNK or p38 MAPK by poly(I:C)[1]. MRT 67307 dihydrochloride (1 nM-10 μM) prevents the production of IFNβ in macrophages[1]. MRT 67307 dihydrochloride (10 μM) is sufficient to reduce phospho-ATG13 to control levels[2]. MRT 67307 dihydrochloride (10 μM) blocks autophagy in mouse embryonic fibroblasts (MEFs)[2]. MRT 67307 dihydrochloride (5 µM; 4 h) abrogates TBK1/IKKε-induced CYLD phosphorylation in 293T cells[3]. |
分子量 | 537.53 |
分子式 | C26H38Cl2N6O2 |
CAS No. | 1781882-89-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 82.8mg/mL (154mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.8604 mL | 9.3018 mL | 18.6036 mL | 46.509 mL |
5 mM | 0.3721 mL | 1.8604 mL | 3.7207 mL | 9.3018 mL | |
10 mM | 0.186 mL | 0.9302 mL | 1.8604 mL | 4.6509 mL | |
20 mM | 0.093 mL | 0.4651 mL | 0.9302 mL | 2.3255 mL | |
50 mM | 0.0372 mL | 0.186 mL | 0.3721 mL | 0.9302 mL | |
100 mM | 0.0186 mL | 0.093 mL | 0.186 mL | 0.4651 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
MRT 67307 dihydrochloride 1781882-89-0 PI3K/Akt/mTOR signaling SIK MRT 67307 Dihydrochloride MRT67307 MRT-67307 MRT 67307 MRT-67307 Dihydrochloride MRT67307 Dihydrochloride Inhibitor inhibitor inhibit